[4] The hospitals which now form part of UCLH or which contributed to its development were all originally established as charities which relied on public donations and subscriptions for their income.

[9] In April 2012 it was announced that UCLH had been selected by the UK Government as one of two sites in England for the provision of Proton Beam Therapy (PBT) (the other being the Christie Hospital in Manchester).

[10] In 2015 the Trust began construction of a new clinical facility adjacent to University College Hospital to house the PBT facilities, and to also contain Europe’s largest haematological inpatient service and a short stay surgical centre.

[17] In August 2016 a partnership between the trust and Google's artificial intelligence division, DeepMind, was announced, as part of which anonymised CT and MRI scans from former University College Hospital radiotherapy patients will be utilised to help develop an algorithm that can automatically differentiate between healthy and cancerous tissues.

The Royal National Throat Nose and Ear Hospital on Gray's Inn Road remains open for wards, theatres, sleep diagnostics and allergy day case services.

The hospital has 665 in-patient beds, 12 operating theatres and houses the largest single critical care unit in the NHS.

The Centre opened in April 2012, with significant support from the UCL Hospitals Charitable Foundation.

It is the only NHS hospital dedicated to the prevention, diagnosis and treatment of tropical diseases and travel-related infections.

It was the first hospital to be established in England dedicated exclusively to treating the diseases of the nervous system.

In partnership with the UCL Institute of Neurology, which occupies the same site, the hospital is a major centre for neuroscience research.

The NHNN also runs The National Brain Appeal, a charity dedicated to supporting the Hospital for the funding of equipment, buildings and research.

[24] It has an education department which offers full and part-time courses in complementary medicine for registered health professionals.

[26] 10 other governors are appointed by local partner organisations including the primary care trust and UCL.

In September 2016 the Centre was awarded £111 million in funding from the National Institute for Health and Care Research for the five years from April 2017.

[29][30] Each of the UCLH hospitals has close research links with the UCL School of Life & Medical Sciences and its institutes and centres.

The original developer, Amec Foster Wheeler sold their 35% stake to Land Securities and their interest passed to Semperian in 2010.

[37] The trust complained in June 2015 that commissioners outside England use a "burdensome" prior approval process, where a funding agreement is needed before each stage of treatment.

[38] It was named by the Health Service Journal as one of the top hundred NHS trusts to work for in 2015.